The COVID-19 disease-specific findings are consistent with the effect of metformin in reducing tumor necrosis factor (TNF-α) levels in women, suggesting that metformin may protect against CCOVID-19 through TNF-α-mediated pathway. This evidence concerns the gene TNF and COVID-19.